Fig. 3From: Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancerForest plots of the pooled RR for disease-free survival (DFS) of concurrent regimens and sequential regimens. The results indicated that there was no significant difference in DFS between concurrent and sequential groups (RR, 1.05; 95% CI, 0.97-1.14; P = 0.22)Back to article page